Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

STAT3-Mediated Metabolic Reprograming in Cellular Transformation and Implications for Drug Resistance
Valeria Poli, Annalisa Camporeale
Frontiers in Oncology (2015) Vol. 5
Open Access | Times Cited: 123

Showing 1-25 of 123 citing articles:

Therapeutically exploiting STAT3 activity in cancer — using tissue repair as a road map
Jennifer Huynh, Ashwini L. Chand, Daniel J. Gough, et al.
Nature reviews. Cancer (2018) Vol. 19, Iss. 2, pp. 82-96
Closed Access | Times Cited: 444
Metformin Enhances Autophagy and Normalizes Mitochondrial Function to Alleviate Aging-Associated Inflammation
Leena P. Bharath, Madhur Agrawal, Grace McCambridge, et al.
Cell Metabolism (2020) Vol. 32, Iss. 1, pp. 44-55.e6
Open Access | Times Cited: 444
Jak Stat signaling and cancer: Opportunities, benefits and side effects of targeted inhibition
Bernd Groner, Viktoria von Manstein
Molecular and Cellular Endocrinology (2017) Vol. 451, pp. 1-14
Closed Access | Times Cited: 270
Do STAT3 inhibitors have potential in the future for cancer therapy?
Andrea L.A. Wong, Jayshree L. Hirpara, Shazib Pervaiz, et al.
Expert Opinion on Investigational Drugs (2017) Vol. 26, Iss. 8, pp. 883-887
Open Access | Times Cited: 214
TGR5, Not Only a Metabolic Regulator
Cong Guo, Weidong Chen, Yan‐Dong Wang
Frontiers in Physiology (2016) Vol. 7
Open Access | Times Cited: 197
Molecular intricacies of aerobic glycolysis in cancer: current insights into the classic metabolic phenotype
Shanmugasundaram Ganapathy‐Kanniappan
Critical Reviews in Biochemistry and Molecular Biology (2018) Vol. 53, Iss. 6, pp. 667-682
Closed Access | Times Cited: 174
Metabolic flexibility determines human NK cell functional fate in the tumor microenvironment
Sophie M. Poznanski, Kanwaldeep Singh, Tyrah M. Ritchie, et al.
Cell Metabolism (2021) Vol. 33, Iss. 6, pp. 1205-1220.e5
Open Access | Times Cited: 174
JAK/STAT Signaling: Molecular Targets, Therapeutic Opportunities, and Limitations of Targeted Inhibitions in Solid Malignancies
Bilal Rah, Rafiq A. Rather, Gh Rasool Bhat, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 132
Tumor-induced reshuffling of lipid composition on the endoplasmic reticulum membrane sustains macrophage survival and pro-tumorigenic activity
Giusy Di Conza, Chin-Hsien Tsai, Héctor Gallart‐Ayala, et al.
Nature Immunology (2021) Vol. 22, Iss. 11, pp. 1403-1415
Open Access | Times Cited: 123
VISTA promotes the metabolism and differentiation of myeloid-derived suppressor cells by STAT3 and polyamine-dependent mechanisms
Keman Zhang, Amin Zakeri, Tyler J. Alban, et al.
Cell Reports (2024) Vol. 43, Iss. 1, pp. 113661-113661
Open Access | Times Cited: 20
STAT3 in cancer: A double edged sword
Lidia Avalle, Annalisa Camporeale, Andrea Camperi, et al.
Cytokine (2017) Vol. 98, pp. 42-50
Open Access | Times Cited: 146
Myosin II Reactivation and Cytoskeletal Remodeling as a Hallmark and a Vulnerability in Melanoma Therapy Resistance
José L. Orgaz, Eva Crosas‐Molist, Amine Sadok, et al.
Cancer Cell (2020) Vol. 37, Iss. 1, pp. 85-103.e9
Open Access | Times Cited: 123
An Update on the Multifaceted Roles of STAT3 in the Heart
Zeina Harhous, George W. Booz, Michel Ovize, et al.
Frontiers in Cardiovascular Medicine (2019) Vol. 6
Open Access | Times Cited: 112
The Process and Regulatory Components of Inflammation in Brain Oncogenesis
AGM Mostofa, Surendra R. Punganuru, Hanumantha Rao Madala, et al.
Biomolecules (2017) Vol. 7, Iss. 2, pp. 34-34
Open Access | Times Cited: 98
Targeting STAT3 with silibinin to improve cancer therapeutics
Joaquim Bosch‐Barrera, Bernardo Queralt, Javier A. Menéndez
Cancer Treatment Reviews (2017) Vol. 58, pp. 61-69
Closed Access | Times Cited: 97
The Mevalonate Pathway, a Metabolic Target in Cancer Therapy
Borja Guerra, Carlota Recio, Haidée Aranda-Tavío, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 97
STAT3 as a mediator of oncogenic cellular metabolism: Pathogenic and therapeutic implications
Isidora Tošić, David A. Frank
Neoplasia (2021) Vol. 23, Iss. 12, pp. 1167-1178
Open Access | Times Cited: 84
Immunometabolic rewiring in tumorigenesis and anti-tumor immunotherapy
Xin Lian, Kailin Yang, Renliang Li, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 67
IL-17 Induces Autophagy Dysfunction to Promote Inflammatory Cell Death and Fibrosis in Keloid Fibroblasts via the STAT3 and HIF-1α Dependent Signaling Pathways
Seon-Yeong Lee, A Ram Lee, Jeong Won Choi, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 42
Nobiletin in Cancer Therapy; Mechanisms and Therapy Perspectives
Reza Moazamiyanfar, Sepideh Rezaei, Hasan Aliashrafzadeh, et al.
Current Pharmaceutical Design (2023) Vol. 29, Iss. 22, pp. 1713-1728
Closed Access | Times Cited: 22
Importance of IL-6 trans-signaling and high autocrine IL-6 production in human osteoarthritic chondrocyte metabolism
Annett Eitner, Christian König, Felix C. Kohler, et al.
Osteoarthritis and Cartilage (2024) Vol. 32, Iss. 5, pp. 561-573
Open Access | Times Cited: 8
Silibinin is a direct inhibitor of STAT3
Sara Verdura, Elisabet Cuyàs, Laura Llorach-Parés, et al.
Food and Chemical Toxicology (2018) Vol. 116, pp. 161-172
Closed Access | Times Cited: 66
STAT3 isoforms: Alternative fates in cancer?
Petra Aigner, Valentin Just, Dagmar Stoiber
Cytokine (2018) Vol. 118, pp. 27-34
Open Access | Times Cited: 66
Glutamine activates STAT3 to control cancer cell proliferation independently of glutamine metabolism
Angela Cacace, Martina Sboarina, Thibaut Vazeille, et al.
Oncogene (2016) Vol. 36, Iss. 15, pp. 2074-2084
Open Access | Times Cited: 65
Overcoming chemo/radio-resistance of pancreatic cancer by inhibiting STAT3 signaling
Xiaoqing Wu, Wenhua Tang, Rebecca T. Marquez, et al.
Oncotarget (2016) Vol. 7, Iss. 10, pp. 11708-11723
Open Access | Times Cited: 64
Page 1 - Next Page

Scroll to top